Clinical Study
Improving Total-Cholesterol/HDL-Cholesterol Ratio Results in an Endothelial Dysfunction Recovery in Peripheral Artery Disease Patients
Table 2
Initial lipid-profile values and values after 1 month of treatment with atorvastatin.
| | Mean ± DS | |
| Total CHOL baseline | 5.4 ± 1.3 mmol L−1 | 0.0001 | Total CHOL after treatment | 3.8 ± 0.1 mmol L−1 | | | | LDL-CHOL baseline | 3.4 ± 1. mmol L−1 | 0.0001 | LDL-CHOL after treatment | 1.8 ± 0.6 mmol L−1 | | | | HDL-CHOL baseline | 1.3 ± 0.3 mmol L−1 | 0.12 | HDL-CHOL after treatment | 1.4 ± 0.4 mmol L−1 | | | | CHOL/HDL baseline | 4 ± 0.9 mmol L−1 | 0.0001 | CHOL/HDL after treatment | 2.7 ± 0.6 mmol L−1 | | | | TGC baseline | 1.3 ± 0.5 mmol L−1 | 0.024 | TGC after treatment | 1.1 ± 0.4 mmol L−1 | | | | TGC/HDL baseline | 2.3 ± 1.3 mmol L−1 | 0.113 | TGC/HDL after treatment | 2 ± 1.2 mmol L−1 |
|
|